Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC), 35644 [2018-16101]

Download as PDF 35644 Federal Register / Vol. 83, No. 145 / Friday, July 27, 2018 / Notices EARLY TERMINATIONS GRANTED—JUNE 1, 2018 THRU JUNE 30, 2018—Continued 20181453 ...... 20181455 ...... G G Elliott International Limited; Sempra Energy; Elliott International Limited. JSW Energy Interests LP; Sempra Energy; JSW Energy Interests LP. 06/29/2018 20181211 ...... G American Well Corporation; Avizia, Inc.; American Well Corporation. FOR FURTHER INFORMATION CONTACT: Theresa Kingsberry, Program Support Specialist, Federal Trade Commission Premerger Notification Office, Bureau of Competition, Room CC–5301, Washington, DC 20024, (202) 326–3100. By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 2018–16025 Filed 7–26–18; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of closed meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC). DATES: The meeting will be held on August 14, 2018, 1:00 p.m. to 3:00 p.m., EDT (CLOSED). ADDRESSES: Teleconference. FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D., M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, GA 30341, Telephone (770) 488–1430, Email address: NCIPCBSC@cdc.gov. SUPPLEMENTARY INFORMATION: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Purpose: The Board of Scientific Counselors makes recommendations regarding policies, strategies, objectives, and priorities; and reviews progress toward injury prevention goals and amozie on DSK3GDR082PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:38 Jul 26, 2018 Jkt 244001 provides evidence in injury preventionrelated research and programs. The Board also provides advice on the appropriate balance of intramural and extramural research, the structure, progress and performance of intramural programs. The Board is designed to provide guidance on extramural scientific program matters, including the: (1) Review of extramural research concepts for funding opportunity announcements; (2) conduct of Secondary Peer Review of extramural research grants, cooperative agreements, and contracts applications received in response to the funding opportunity announcements as it relates to the Center’s programmatic balance and mission; (3) submission of secondary review recommendations to the Center Director of applications to be considered for funding support; (4) review of research portfolios, and (5) review of program proposals. Matters To Be Considered: The agenda will include discussions on Secondary Peer Review of extramural research grant and cooperative agreement applications received in response to one (1) Notice of Funding Opportunity (NOFO): RFA–CE–18–006, Research Grants for Primary or Secondary Prevention of Opioid Overdose (RO1). Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dia Taylor, Acting Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2018–16101 Filed 7–26–18; 8:45 am] BILLING CODE 4163–19–P PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Health Statistics (NCHS), ICD–10 Coordination and Maintenance (C&M) Committee Meeting Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: The CDC, National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, announces the following meeting of the ICD–10 Coordination and Maintenance (C&M) Committee meeting. This meeting is open to the public, limited only by the space available. The meeting room accommodates approximately 240 people. We will be broadcasting the meeting live via Webcast at hhtp:// www.cms.gov/live/. DATES: The meeting will be held on September 11, 2018, 9:00 a.m. to 5:00 p.m. EDT and September 12, 2018, 9:00 a.m. to 5:00 p.m. EDT. ADDRESSES: Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland 21244. FOR FURTHER INFORMATION CONTACT: Traci Ramirez, Program Specialist, CDC, 3311 Toledo Rd., Hyattsville, MD 20782 telephone (301) 458–4454; email address TRamirez@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The ICD–10 Coordination and Maintenance (C&M) Committee is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Tenth Revision, Clinical Modification and ICD–10 Procedure Coding System. Matters To Be Considered: The agenda will include discussions on ICD–10– PCS Topics: Intraoperative Fluorescence Vascular Angiography for Lymphatic Mapping in Cervical and Uterine Cancers Insertion of Intramedullary Nail Limb Lengthening System Cell Suspension Autografting—REPEAT Subcutaneous Implantable Defibrillator System SUMMARY: E:\FR\FM\27JYN1.SGM 27JYN1

Agencies

[Federal Register Volume 83, Number 145 (Friday, July 27, 2018)]
[Notices]
[Page 35644]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16101]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Injury 
Prevention and Control (BSC, NCIPC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of closed meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
National Center for Injury Prevention and Control (BSC, NCIPC).

DATES: The meeting will be held on August 14, 2018, 1:00 p.m. to 3:00 
p.m., EDT (CLOSED).

ADDRESSES: Teleconference.

FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D., 
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 
Buford Highway NE, Mailstop F-63, Atlanta, GA 30341, Telephone (770) 
488-1430, Email address: [email protected].

SUPPLEMENTARY INFORMATION: The meeting will be closed to the public in 
accordance with provisions set forth in Section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
    Purpose: The Board of Scientific Counselors makes recommendations 
regarding policies, strategies, objectives, and priorities; and reviews 
progress toward injury prevention goals and provides evidence in injury 
prevention-related research and programs. The Board also provides 
advice on the appropriate balance of intramural and extramural 
research, the structure, progress and performance of intramural 
programs. The Board is designed to provide guidance on extramural 
scientific program matters, including the: (1) Review of extramural 
research concepts for funding opportunity announcements; (2) conduct of 
Secondary Peer Review of extramural research grants, cooperative 
agreements, and contracts applications received in response to the 
funding opportunity announcements as it relates to the Center's 
programmatic balance and mission; (3) submission of secondary review 
recommendations to the Center Director of applications to be considered 
for funding support; (4) review of research portfolios, and (5) review 
of program proposals.
    Matters To Be Considered: The agenda will include discussions on 
Secondary Peer Review of extramural research grant and cooperative 
agreement applications received in response to one (1) Notice of 
Funding Opportunity (NOFO): RFA-CE-18-006, Research Grants for Primary 
or Secondary Prevention of Opioid Overdose (RO1). Agenda items are 
subject to change as priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Dia Taylor,
Acting Chief Operating Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2018-16101 Filed 7-26-18; 8:45 am]
 BILLING CODE 4163-19-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.